Chronic hepatitis is often clinically silent until advanced fibrosis, cirrhosis, or hepatocellular carcinoma develops, making primary care the highest-value point for early detection and prevention rather than late-stage management. From the AAVBC's perspective, value-based care begins by closing persistent screening gaps, recognizing that abnormal liver tests should trigger diagnostic evaluation—not be attributed to aging or comorbidity—and managing chronic hepatitis as a longitudinal condition requiring risk stratification, surveillance, and individualized treatment rather than an isolated laboratory abnormality. Common primary care pitfalls, including failure to apply age-adjusted FIB-4 interpretation in adults ≥65 years, delayed antiviral treatment, and inadequate surveillance planning, can lead to unnecessary testing, missed diagnoses, and preventable complications.
AAVBC's Chronic Hepatitis Quick Reference Guide focuses on the clinical decisions where primary care creates the greatest value. Drawing from current AASLD, AASLD-IDSA HCV Guidance, CDC, USPSTF, and EASL recommendations, it addresses etiology-specific ICD-10 coding, age-adjusted fibrosis staging, MEAT documentation, HCC surveillance, antiviral selection in older adults with polypharmacy, and evidence supporting timely treatment regardless of age. It also connects chronic hepatitis management to reportable quality measures—including hepatitis-specific MIPS measures for screening, treatment initiation, HBV testing before immunosuppression, and sustained virologic response, alongside relevant HEDIS measures for vaccination and substance use—helping primary care teams improve documentation, accountability, and long-term patient outcomes.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic hepatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Chronic hepatitis is often clinically silent until advanced fibrosis, cirrhosis, or hepatocellular carcinoma develops, making primary care the highest-value point for early detection and prevention rather than late-stage management. From the AAVBC's perspective, value-based care begins by closing persistent screening gaps, recognizing that abnormal liver tests should trigger diagnostic evaluation—not be attributed to aging or comorbidity—and managing chronic hepatitis as a longitudinal condition requiring risk stratification, surveillance, and individualized treatment rather than an isolated laboratory abnormality. Common primary care pitfalls, including failure to apply age-adjusted FIB-4 interpretation in adults ≥65 years, delayed antiviral treatment, and inadequate surveillance planning, can lead to unnecessary testing, missed diagnoses, and preventable complications.
AAVBC's Chronic Hepatitis Quick Reference Guide focuses on the clinical decisions where primary care creates the greatest value. Drawing from current AASLD, AASLD-IDSA HCV Guidance, CDC, USPSTF, and EASL recommendations, it addresses etiology-specific ICD-10 coding, age-adjusted fibrosis staging, MEAT documentation, HCC surveillance, antiviral selection in older adults with polypharmacy, and evidence supporting timely treatment regardless of age. It also connects chronic hepatitis management to reportable quality measures—including hepatitis-specific MIPS measures for screening, treatment initiation, HBV testing before immunosuppression, and sustained virologic response, alongside relevant HEDIS measures for vaccination and substance use—helping primary care teams improve documentation, accountability, and long-term patient outcomes.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic hepatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
